Relying on J&J's analyses to assess vaccine booster dose data -U.S. FDA staff


Reuters | Washington DC | Updated: 13-10-2021 20:12 IST | Created: 13-10-2021 20:11 IST
Relying on J&J's analyses to assess vaccine booster dose data -U.S. FDA staff
Representative image Image Credit: ANI
  • Country:
  • United States

U.S. Food and Drug Administration scientists said on Wednesday they did not have time to analyze data submitted by Johnson & Johnson on a booster dose of its single-dose COVID-19 vaccine, in a rare case where the agency relied on a company's analyses to brief its advisory panel.

An outside panel of experts will meet on Friday to discuss whether a booster dose of J&J's vaccine is safe and effective anywhere between two months and six months after taking the original dose.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback